Jaguar Health, Inc.
JAGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,502 | -$10,583 | -$10,464 | -$9,920 |
| Dep. & Amort. | $560 | $556 | $546 | $593 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $279 | $301 | $0 |
| Change in WC | $2,045 | $623 | $1,319 | -$1,439 |
| Other Non-Cash | $2,208 | $2,932 | $982 | $2,940 |
| Operating Cash Flow | -$4,689 | -$6,193 | -$7,316 | -$7,826 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$54 | $0 | $0 | -$215 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$54 | $0 | $0 | -$215 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$199 | -$148 | $3,210 | -$171 |
| Stock Issued | $6,458 | $1,494 | $1,756 | $3,001 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1,309 | $0 | $0 |
| Financing Cash Flow | $6,259 | $2,655 | $4,966 | $2,830 |
| Forex Effect | -$196 | $57 | $36 | -$56 |
| Net Chg. in Cash | $1,320 | -$3,481 | -$2,314 | -$5,267 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,207 | $5,688 | $8,002 | $13,269 |
| End Cash | $3,527 | $2,207 | $5,688 | $8,002 |
| Free Cash Flow | -$4,743 | -$6,193 | -$7,316 | -$7,826 |